Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas
- PMID: 112482
- DOI: 10.1007/BF00507101
Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas
Abstract
Glibenclamide, a "second generation" sulfonylurea, produced the same pattern of insulin release from the perfused rat pancreas as did tolbutamide. The stimulatory effect was closely dependent on the glucose concentration present. Both agents enhanced insulin secretion at 5--10 mM glucose, whereas no additional insulin was released when maximally stimulating levels of glucose (20 and 30 mM) were present. The concentrations of glibenclamide stimulating insulin release were 100--400 times lower than equieffective levels of tolbutamide. At glucose levels of 3 or 8 mM, however, glibenclamide did not liberate significantly more insulin from the pancreas than did tolbutamide. Thus the differences of tolbutamide and glibenclamide were quantitative rather than qualitative. Although the active concentrations differed the effects produced were comparable.
Similar articles
-
Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.Diabetes Res Clin Pract. 1992 Dec;18(3):197-206. doi: 10.1016/0168-8227(92)90146-i. Diabetes Res Clin Pract. 1992. PMID: 1289021
-
Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.Diabetologia. 1976 Aug;12(4):339-42. doi: 10.1007/BF00420977. Diabetologia. 1976. PMID: 134920
-
Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.J Diabetes Complications. 1994 Oct-Dec;8(4):204-12. doi: 10.1016/1056-8727(94)90045-0. J Diabetes Complications. 1994. PMID: 7833495
-
Microtubules and beta cell secretion.Recent Prog Horm Res. 1973;29:199-228. doi: 10.1016/b978-0-12-571129-6.50009-9. Recent Prog Horm Res. 1973. PMID: 4584365 Review. No abstract available.
-
The pharmacology and metabolism of oral antidiabetic drugs.Aust N Z J Med. 1971 Aug;1:Suppl 2:22-30. doi: 10.1111/j.1445-5994.1971.tb02572.x. Aust N Z J Med. 1971. PMID: 5005129 Review. No abstract available.
Cited by
-
Sulfonylurea Receptor Pharmacology Alters the Performance of Two Central Pattern Generating Circuits in Cancer borealis.Function (Oxf). 2024 Nov 20;5(6):zqae043. doi: 10.1093/function/zqae043. Function (Oxf). 2024. PMID: 39293809 Free PMC article.
-
Sulfonylurea receptor coupled conductances alter the performace of two central pattern generating circuits in Cancer borealis.bioRxiv [Preprint]. 2024 Jul 13:2024.07.09.602760. doi: 10.1101/2024.07.09.602760. bioRxiv. 2024. Update in: Function (Oxf). 2024 Nov 20;5(6):zqae043. doi: 10.1093/function/zqae043. PMID: 39026863 Free PMC article. Updated. Preprint.
-
Tolbutamide potentiates the volume-regulated anion channel current in rat pancreatic beta cells.Diabetologia. 2004 Nov;47(11):1990-7. doi: 10.1007/s00125-004-1559-4. Epub 2004 Nov 24. Diabetologia. 2004. PMID: 15565369